Comparative study between continuous adductor canal block versus continuous epidural infusion for postoperative analgesia in patients with unilateral total knee arthroplasty.

Randomized control trial comparing analgesia using continuous adductor canal block versus continuous epidural infusion in patients with unilateral total knee arthroplasty.

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/07/034930

Enrollment

Registered

2021-07-16

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: usg guided adductor canal block with combined spinal epidural anaesthesia: usg guided adductor canal block with combined spinal epidural anaesthesia with 0.08% ropivacaine at 8-14ml/hou

Eligibility

Inclusion criteria

Inclusion criteria: 1.American Society of Anaesthesiologists (ASA) grade 1, 2, 3 of unilateral total knee arthroplasty. 2.Age group of 30 â?? 90 years of both sexes. 3.Patients giving valid informed consent.

Exclusion criteria

Exclusion criteria: 1.Patient refusal. 2.Bilateral total knee arthroplasty. 3.Both epidural and adductor canal catheter used. 4.Body mass index (BMI) greater than 40. 5.History of drug or alcohol abuse and drug allergy, physically dependent on narcotics. 6.Contraindication to either spinal or general anaesthesia. 7.Patients with localized skin sepsis, haemorrhagic diathesis or neurological involvement/ diseases. 8.Patients with significant spinal deformity, history of chronic backache and headache.

Design outcomes

Primary

Measure	Time frame
Assessing and comparing pain (VAS) score.Timepoint: 5 months	—

Secondary

Measure	Time frame
Total dose of analgesic used in 48 hours period (postoperative). â?¢ Range of motion, ambulation distance, average rate of infusion and catheter removal time is measured. â?¢ Any adverse/side effects â?¢ Urinary retention â?¢ Nausea, vomiting â?¢ HypotensionTimepoint: 5 months	—

Countries

India

Contacts

Public ContactDr Mohammed Hassim Nawab Ali Ansari

Dr.L.H.Hiranandani Hospital,Powai,Mumbai

dramolpradhan@gmail.com9819390204

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026